Valeshvar Bio Tech Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
- Paid Up Capital ₹ 3.26 Cr
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.02 Cr
- Revenue Growth -16.40%
- Profit Growth -72.58%
- Ebitda -35.83%
- Net Worth 1.67%
- Total Assets 5.71%
About Valeshvar Bio Tech
Valeshvar Bio Tech Private Limited (VBTPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2019 (Five years and 11 months 19 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.26 Cr.
The company currently has active open charges totaling ₹13.02 Cr.
Maheshbhai Kumbhani, Muralidhar Ingale, and Jayeshkumar Pidhadiya serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24290GJ2019PTC106555
- Company No.
106555
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Valeshvar Bio Tech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muralidhar Ingale  | Director | 03-May-2021 | Current |
| Maheshbhai Kumbhani | Director | 12-Feb-2019 | Current |
| Jayeshkumar Pidhadiya | Director | 12-Feb-2019 | Current |
Financial Performance of Valeshvar Bio Tech.
Valeshvar Bio Tech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.4% decrease. The company also saw a substantial fall in profitability, with a 72.58% decrease in profit. The company's net worth moved up by a moderate rise of 1.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valeshvar Bio Tech?
In 2023, Valeshvar Bio Tech had a promoter holding of 89.26% and a public holding of 10.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nishant Organics Private LimitedMuralidhar Ingale is a mutual person
Bhavani Interchem Private LimitedMaheshbhai Kumbhani and Jayeshkumar Pidhadiya are mutual person
Charges (Loans)
₹13.02 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 13.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2019 | Axis Bank Limited | ₹6.51 Cr | Open |
| 30 Jul 2019 | Axis Bank Limited | ₹6.51 Cr | Open |
How Many Employees Work at Valeshvar Bio Tech?
Valeshvar Bio Tech has a workforce of 43 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valeshvar Bio Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valeshvar Bio Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.